Health News Releases

  • Today May 21
February 15, 2016 11:15
CiteAb Names Cell Signaling Technology, “Antibody Company of the Year” and “Researchers’ Choice”
Cell Signaling Technology (CST), a leading provider of antibodies, kits and services, was honored with the 2016 CiteAb Award for “Researchers’ Choice” and for a second year in a row with the award for
February 12, 2016 13:05
Morinaga Milk's B. longum BB536 Probiotic May Prevent Intestinal Disorders Induced by Animal-Based Diet
Morinaga Milk Industry Co., Ltd. (www.morinagamilk.co.jp/english) (TOKYO:2264), a leading dairy product company in Japan, today unveiled new research showing that daily consumption of yogurt fortified
February 11, 2016 14:25
The European Society of Cardiology announces winners of innovative cardiovascular research grant programme
The European Society of Cardiology (ESC) has announced five winners of the competitive research programme ‘Grants for Medical Research Innovation’, exclusively supported by an independent grant from B
February 10, 2016 15:25
Ferring announces the start of the PRONOUNCE Trial for patients with advanced prostate cancer and cardiovascular disease receiving degarelix or leuprolide
Ferring Pharmaceuticals announced today the commencement of the Phase 3b PRONOUNCE Trial. The trial will compare the occurrence of major adverse cardiovascular events (MACEs) in patients with prostate
February 10, 2016 14:00
ASTRAZENECA’S COMBINATION OF DURVALUMAB WITH TREMELIMUMAB SHOWS CLINICAL ACTIVITY IN NON-SMALL CELL LUNG CANCER IRRESPECTIVE OF PD-L1 STATUS
AstraZeneca and MedImmune, its global biologics research and development arm, today announced publication in The Lancet Oncology of a Phase Ib study (study 006), showing antitumour activity of combina
February 10, 2016 12:00
Quintiles Wins 2016 Leadership Excellence Award
Quintiles, the world’s largest biopharmaceutical services company, has been awarded the HR.com 2016 Leadership Excellence Award for Innovation in Deployment of Leadership Programs. This Smart News
February 05, 2016 14:00
In New Clinical Study Masimo’s Oxygen Reserve Index Helps Clinicians Detect Impending Desaturation in Pediatric Patients
Masimo (www.masimo.com) (NASDAQ: MASI) announced today that in a new clinical study, Masimo’s Oxygen Reserve Index (ORI™), the first noninvasive and continuous parameter to provide insight into patien
February 04, 2016 18:35
SPIRIVA® RESPIMAT® Now Available in the U.S. for Maintenance Treatment of Asthma in Adults and Adolescents
Boehringer Ingelheim today announced that SPIRIVA® RESPIMAT® is now available for the treatment of asthma by prescription in U.S. pharmacies. The U.S. Food and Drug Administration (FDA) approved a onc
February 04, 2016 17:10
NAMSA Announces Divestiture of its Sterility Assurance Products Division
North American Science Associates, Inc. (NAMSA), the world’s leading medical research organization (MRO®) today announced a definitive agreement to divest its Sterility Assurance Products Division of
February 04, 2016 13:45
Mersana Therapeutics and Takeda Expand Partnership to Advance Development of Fleximer® Antibody-Drug Conjugates and XMT-1522
Mersana Therapeutics (www.mersana.com) and Takeda Pharmaceutical Company Limited (http://betterhealth.takeda.com) (TSE:4502) today announced that they have entered a new strategic partnership granting
February 04, 2016 13:15
Takeda Reports Results for Three Quarters (April-December) of FY2015, Reaffirms Management Guidance for the Full Year
Takeda Pharmaceutical Company Limited (TOKYO:4502): Results of April to December period reaffirms full-year management guidance · Underlying revenue +3.8% year-to-year (reported revenue growing
February 04, 2016 06:00
The Health Industry Summit Stirs Investor Frenzy Over China’s Healthcare Sector With Double-Digit Growth
In the summer of 2015, an event drew record-breaking single-day crowds of over 170,000 professionals to Shanghai solely for the healthcare sector. It was a mega trade event combining the top medical a
January 27, 2016 17:25
Boehringer Ingelheim’s Giotrif® / Gilotrif® (afatinib) demonstrated superiority to Iressa® (gefitinib) in reducing the risk of disease progression and treatment failure in first-line treatment of...
Boehringer Ingelheim’s Giotrif® / Gilotrif® (afatinib) demonstrated superiority to Iressa® (gefitinib) in reducing the risk of disease progression and treatment failure in first-line treatment of pati
January 25, 2016 11:15
Kyoto University and Panasonic Developed New Remote Sensing Technology for Vital Signs by Millimeter-wave Radar
Kyoto University and Panasonic Corporation today announced that they developed a new remote sensing technology for vital signs such as heart rate, heartbeat interval and others. This technology consis
January 22, 2016 17:05
European Commission Approves Label Variation for ADCETRIS® (Brentuximab Vedotin) to Include Data on Retreatment of Adult Patients with Relapsed or Refractory Hodgkin Lymphoma and Systemic Anaplastic Large Cell Lymphoma (sALCL)
Takeda Pharmaceutical Company Limited (http://betterhealth.takeda.com/) (TSE:4502) today announced that the European Commission (EC) has approved a Type II variation for ADCETRIS® (brentuximab vedotin
January 21, 2016 11:15
Morinaga Milk Opens New Subsidiary in Singapore
Morinaga Milk Industry Co., Ltd. (www.morinagamilk.co.jp/english) (TOKYO:2264), the leading dairy product company in Japan, today announced the establishment of its new subsidiary, Morinaga Nutritiona
January 20, 2016 15:00
AtriCure Announces Approval for the AtriClip in Japan
AtriCure, Inc. (www.atricure.com) (Nasdaq: ATRC) (http://goo.gl/JedfVJ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced th
January 18, 2016 09:20
Samsung Bioepis Enters the European Biopharmaceutical Market with Benepali®, the First Fusion Protein Biosimilar Approved by the European Commission
Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) approval of Benepali® - a biosimilar referencing Enbrel® (etanercept), also known as SB4 - for the treatment of rheumatoid arth
January 13, 2016 23:45
GE Healthcare, FedDev Ontario Commit CAD $40M for New CCRM-Led Centre to Solve Cell Therapy Manufacturing Challenges
GE Healthcare, the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), and the Centre for Commercialization of Regenerative Medicine (CCRM) are building a centre for advanced th
January 13, 2016 17:55
Boehringer Ingelheim and Arena Pharmaceuticals Collaborate to Advance Research in Schizophrenia
Boehringer Ingelheim and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that they have signed an exclusive agreement to conduct joint research to identify drug candidates targeting an undi
January 13, 2016 13:25
First Implant Completed in Thoracoabdominal Aortic Aneurysm Clinical Study
W. L. Gore & Associates, Inc. (Gore) today announced the first implant in the United States of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in a clinical study for the treatment of aorti
January 12, 2016 17:00
Takeda to Present at the 34th Annual J.P. Morgan Healthcare Conference
Takeda Pharmaceutical Company Limited (TOKYO: 4502) (http://goo.gl/eX9kbP) (“Takeda”) today announced that Christophe Weber, President and Chief Executive Officer of Takeda, will make a formal present
January 12, 2016 13:55
Takeda and enGene Establish Strategic Alliance to Develop Novel Therapeutics for Gastrointestinal Diseases
Takeda Pharmaceutical Company Ltd. (TOKYO:4502) (http://goo.gl/eX9kbP) and enGene, Inc. today announced a strategic alliance to discover, develop and commercialize novel therapies for specialty gastro
January 07, 2016 03:30
Takeda Acquires U.S. Biologics Manufacturing Facility
Takeda Pharmaceutical Company Limited (TOKYO:4502) (http://goo.gl/eX9kbP) (“Takeda”) today announced the acquisition of a biologics manufacturing facility located in Brooklyn Park, Minnesota, U.S., fr
January 05, 2016 16:50
Bioventus Launches DUROLANE® for Osteoarthritis Patients in Taiwan
Bioventus (www.bioventusglobal.com), a leader in orthobiologic solutions, today announced its entry into the patient care market in Taiwan with the launch of DUROLANE®, a single-injection joint-fluid
25 per page50 per page75 per page100 per page